BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Angeli A, Carta F, Nocentini A, Winum JY, Zalubovskis R, Akdemir A, Onnis V, Eldehna WM, Capasso C, Simone G, Monti SM, Carradori S, Donald WA, Dedhar S, Supuran CT. Carbonic Anhydrase Inhibitors Targeting Metabolism and Tumor Microenvironment. Metabolites 2020;10:E412. [PMID: 33066524 DOI: 10.3390/metabo10100412] [Cited by in Crossref: 28] [Cited by in F6Publishing: 53] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Najm MAA, Mahmoud WR, Taher AT, Abbas SE, Awadallah FM, Allam HA, Vullo D, Supuran CT. Design and synthesis of some new benzoylthioureido phenyl derivatives targeting carbonic anhydrase enzymes. J Enzyme Inhib Med Chem 2022;37:2702-9. [PMID: 36168122 DOI: 10.1080/14756366.2022.2126463] [Reference Citation Analysis]
2 Al-Warhi T, Elbadawi MM, Bonardi A, Nocentini A, Al-Karmalawy AA, Aljaeed N, Alotaibi OJ, Abdel-Aziz HA, Supuran CT, Eldehna WM. Design and synthesis of benzothiazole-based SLC-0111 analogues as new inhibitors for the cancer-associated carbonic anhydrase isoforms IX and XII. J Enzyme Inhib Med Chem 2022;37:2635-43. [PMID: 36146927 DOI: 10.1080/14756366.2022.2124409] [Reference Citation Analysis]
3 Thacker PS, Newaskar V, Angeli A, Sigalapalli DK, Goud NS, Chirra H, Shaik AB, Arifuddin M, Supuran CT. Synthesis and biological evaluation of coumarin-thiazole hybrids as selective carbonic anhydrase IX and XII inhibitors. Arch Pharm (Weinheim) 2022;:e2200232. [PMID: 36122182 DOI: 10.1002/ardp.202200232] [Reference Citation Analysis]
4 Ibrahim HS, Abdelrahman MA, Nocentini A, Bua S, Abdel-aziz HA, Supuran CT, Abou-seri SM, Eldehna WM. Insights into the effect of elaborating coumarin-based aryl enaminones with sulfonamide or carboxylic acid functionality on carbonic anhydrase inhibitory potency and selectivity. Bioorganic Chemistry 2022;126:105888. [DOI: 10.1016/j.bioorg.2022.105888] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Beatriz Vermelho A, Rodrigues GC, Nocentini A, Mansoldo FRP, Supuran CT. Discovery of novel drugs for Chagas disease: is carbonic anhydrase a target for antiprotozoal drugs? Expert Opin Drug Discov 2022;:1-12. [PMID: 36039500 DOI: 10.1080/17460441.2022.2117295] [Reference Citation Analysis]
6 Moi D, Deplano A, Angeli A, Balboni G, Supuran CT, Onnis V. Synthesis of Sulfonamides Incorporating Piperidinyl-Hydrazidoureido and Piperidinyl-Hydrazidothioureido Moieties and Their Carbonic Anhydrase I, II, IX and XII Inhibitory Activity. Molecules 2022;27:5370. [DOI: 10.3390/molecules27175370] [Reference Citation Analysis]
7 Maurya VK, Szwarc MM, Fernandez-Valdivia R, Lonard DM, Yong S, Joshi N, Fazleabas AT, Lydon JP. Early growth response 1 transcription factor is essential for the pathogenic properties of human endometriotic epithelial cells. Reproduction 2022;164:41-54. [PMID: 35679138 DOI: 10.1530/REP-22-0123] [Reference Citation Analysis]
8 Abdoli M, Giovannuzzi S, Supuran CT, Žalubovskis R. 4-(3-Alkyl/benzyl-guanidino)benzenesulfonamides as selective carbonic anhydrase VII inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:1568-76. [DOI: 10.1080/14756366.2022.2080816] [Reference Citation Analysis]
9 Siwach K, Kumar A, Panchal H, Kumar R, Bhardwaj JK, Angeli A, Supuran CT, Sharma PK. Selective inhibition of carbonic anhydrase IX by sulphonylated 1,2,3-triazole incorporated benzenesulphonamides capable of inducing apoptosis. J Enzyme Inhib Med Chem 2022;37:1454-63. [PMID: 35616287 DOI: 10.1080/14756366.2022.2077333] [Reference Citation Analysis]
10 Nerella SG, Singh P, Arifuddin M, Supuran CT. Anticancer carbonic anhydrase inhibitors: a patent and literature update 2018-2022. Expert Opin Ther Pat 2022. [PMID: 35616541 DOI: 10.1080/13543776.2022.2083502] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
11 Tajik M, Baharfar M, Donald WA. Single-cell mass spectrometry. Trends Biotechnol 2022:S0167-7799(22)00102-0. [PMID: 35562238 DOI: 10.1016/j.tibtech.2022.04.004] [Reference Citation Analysis]
12 Kciuk M, Gielecińska A, Mujwar S, Mojzych M, Marciniak B, Drozda R, Kontek R. Targeting carbonic anhydrase IX and XII isoforms with small molecule inhibitors and monoclonal antibodies. J Enzyme Inhib Med Chem 2022;37:1278-98. [PMID: 35506234 DOI: 10.1080/14756366.2022.2052868] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
13 Tanini D, Capperucci A, Locuoco M, Ferraroni M, Costantino G, Angeli A, Supuran CT. Benzoselenoates: A novel class of carbonic anhydrase inhibitors. Bioorg Chem 2022;122:105751. [PMID: 35344894 DOI: 10.1016/j.bioorg.2022.105751] [Reference Citation Analysis]
14 Bonardi A, Bua S, Combs J, Lomelino C, Andring J, Osman SM, Toti A, Di Cesare Mannelli L, Gratteri P, Ghelardini C, Mckenna R, Nocentini A, Supuran CT. The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. Journal of Enzyme Inhibition and Medicinal Chemistry 2022;37:930-9. [DOI: 10.1080/14756366.2022.2053526] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Huo Z, Bilang R, Supuran CT, von der Weid N, Bruder E, Holland-Cunz S, Martin I, Muraro MG, Gros SJ. Perfusion-Based Bioreactor Culture and Isothermal Microcalorimetry for Preclinical Drug Testing with the Carbonic Anhydrase Inhibitor SLC-0111 in Patient-Derived Neuroblastoma. Int J Mol Sci 2022;23:3128. [PMID: 35328549 DOI: 10.3390/ijms23063128] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Khatua S, Taraphder S. In the footsteps of an inhibitor unbinding from the active site of human carbonic anhydrase II. Journal of Biomolecular Structure and Dynamics. [DOI: 10.1080/07391102.2022.2048075] [Reference Citation Analysis]
17 Mustafa M, Winum JY. The importance of sulfur-containing motifs in drug design and discovery. Expert Opin Drug Discov 2022;:1-12. [PMID: 35193437 DOI: 10.1080/17460441.2022.2044783] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 5.0] [Reference Citation Analysis]
18 Merabti A, Roger M, Nguyen C, Nocentini A, Gerbier P, Richeter S, Gary‐bobo M, Supuran CT, Clément S, Winum J. Carbonic Anhydrase Inhibitors Featuring a Porphyrin Scaffold: Synthesis, Optical and Biological Properties. European J Organic Chem. [DOI: 10.1002/ejoc.202101538] [Reference Citation Analysis]
19 Krymov SK, Scherbakov AM, Salnikova DI, Sorokin DV, Dezhenkova LG, Ivanov IV, Vullo D, De Luca V, Capasso C, Supuran CT, Shchekotikhin AE. Synthesis, biological evaluation, and in silico studies of potential activators of apoptosis and carbonic anhydrase inhibitors on isatin-5-sulfonamide scaffold. Eur J Med Chem 2022;228:113997. [PMID: 34902732 DOI: 10.1016/j.ejmech.2021.113997] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
20 Queen A, Bhutto HN, Yousuf M, Syed MA, Hassan MI. Carbonic anhydrase IX: A tumor acidification switch in heterogeneity and chemokine regulation. Semin Cancer Biol 2022:S1044-579X(22)00001-3. [PMID: 34998944 DOI: 10.1016/j.semcancer.2022.01.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Havránková E, Garaj V, Mascaretti Š, Angeli A, Soldánová Z, Kemka M, Motyčka J, Brázdová M, Csöllei J, Jampílek J, Supuran CT. Novel 1,3,5-Triazinyl Aminobenzenesulfonamides Incorporating Aminoalcohol, Aminochalcone and Aminostilbene Structural Motifs as Potent Anti-VRE Agents, and Carbonic Anhydrases I, II, VII, IX, and XII Inhibitors. Int J Mol Sci 2021;23:231. [PMID: 35008657 DOI: 10.3390/ijms23010231] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Biagiotti G, Angeli A, Giacomini A, Toniolo G, Landini L, Salerno G, Di Cesare Mannelli L, Ghelardini C, Mello T, Mussi S, Ravelli C, Marelli M, Cicchi S, Menna E, Ronca R, Supuran CT, Richichi B. Glyco-Coated CdSe/ZnS Quantum Dots as Nanoprobes for Carbonic Anhydrase IX Imaging in Cancer Cells. ACS Appl Nano Mater 2021;4:14153-60. [PMID: 34970641 DOI: 10.1021/acsanm.1c03603] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
23 Supuran CT. Carbonic anhydrase inhibitors: an update on experimental agents for the treatment and imaging of hypoxic tumors. Expert Opin Investig Drugs 2021;:1-12. [PMID: 34865569 DOI: 10.1080/13543784.2021.2014813] [Cited by in Crossref: 1] [Cited by in F6Publishing: 20] [Article Influence: 1.0] [Reference Citation Analysis]
24 Elimam DM, Elgazar AA, Bonardi A, Abdelfadil M, Nocentini A, El-Domany RA, Abdel-Aziz HA, Badria FA, Supuran CT, Eldehna WM. Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation. Eur J Med Chem 2021;225:113800. [PMID: 34482273 DOI: 10.1016/j.ejmech.2021.113800] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
25 Huang P, Xu M, Han H, Zhao X, Li MD, Yang Z. Integrative Analysis of Epigenome and Transcriptome Data Reveals Aberrantly Methylated Promoters and Enhancers in Hepatocellular Carcinoma. Front Oncol 2021;11:769390. [PMID: 34858848 DOI: 10.3389/fonc.2021.769390] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
26 Lemon N, Canepa E, Ilies MA, Fossati S. Carbonic Anhydrases as Potential Targets Against Neurovascular Unit Dysfunction in Alzheimer’s Disease and Stroke. Front Aging Neurosci 2021;13:772278. [DOI: 10.3389/fnagi.2021.772278] [Cited by in Crossref: 1] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
27 Luchinat E, Barbieri L, Cremonini M, Pennestri M, Nocentini A, Supuran CT, Banci L. Determination of intracellular protein-ligand binding affinity by competition binding in-cell NMR. Acta Crystallogr D Struct Biol 2021;77:1270-81. [PMID: 34605430 DOI: 10.1107/S2059798321009037] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
28 Aimene Y, Eychenne R, Rodriguez F, Mallet-ladeira S, Saffon-merceron N, Winum J, Nocentini A, Supuran CT, Benoist E, Seridi A. Synthesis, Crystal Structure, Inhibitory Activity and Molecular Docking of Coumarins/Sulfonamides Containing Triazolyl Pyridine Moiety as Potent Selective Carbonic Anhydrase IX and XII Inhibitors. Crystals 2021;11:1076. [DOI: 10.3390/cryst11091076] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
29 Di Fiore A, Supuran CT, Scaloni A, De Simone G. Post-translational modifications in tumor-associated carbonic anhydrases. Amino Acids 2021. [PMID: 34436666 DOI: 10.1007/s00726-021-03063-y] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
30 Mancuso F, Di Fiore A, De Luca L, Angeli A, De Simone G, Supuran CT, Gitto R. Design, synthesis and biochemical evaluation of novel carbonic anhydrase inhibitors triggered by structural knowledge on hCA VII. Bioorg Med Chem 2021;44:116279. [PMID: 34216985 DOI: 10.1016/j.bmc.2021.116279] [Reference Citation Analysis]
31 Mishra CB, Mongre RK, Prakash A, Jeon R, Supuran CT, Lee MS. Anti-breast cancer action of carbonic anhydrase IX inhibitor 4-[4-(4-Benzo[1,3]dioxol-5-ylmethyl-piperazin-1-yl)-benzylidene-hydrazinocarbonyl]-benzenesulfonamide (BSM-0004): in vitro and in vivo studies. J Enzyme Inhib Med Chem 2021;36:954-63. [PMID: 33947294 DOI: 10.1080/14756366.2021.1909580] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
32 De Luca V, Petreni A, Carginale V, Scaloni A, Supuran CT, Capasso C. Effect of amino acids and amines on the activity of the recombinant ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:1000-6. [PMID: 33980103 DOI: 10.1080/14756366.2021.1919891] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
33 Nocentini A, Angeli A, Carta F, Winum JY, Zalubovskis R, Carradori S, Capasso C, Donald WA, Supuran CT. Reconsidering anion inhibitors in the general context of drug design studies of modulators of activity of the classical enzyme carbonic anhydrase. J Enzyme Inhib Med Chem 2021;36:561-80. [PMID: 33615947 DOI: 10.1080/14756366.2021.1882453] [Cited by in Crossref: 12] [Cited by in F6Publishing: 44] [Article Influence: 12.0] [Reference Citation Analysis]
34 Meleddu R, Deplano S, Maccioni E, Ortuso F, Cottiglia F, Secci D, Onali A, Sanna E, Angeli A, Angius R, Alcaro S, Supuran CT, Distinto S. Selective inhibition of carbonic anhydrase IX and XII by coumarin and psoralen derivatives. J Enzyme Inhib Med Chem 2021;36:685-92. [PMID: 33602041 DOI: 10.1080/14756366.2021.1887171] [Cited by in Crossref: 1] [Cited by in F6Publishing: 9] [Article Influence: 1.0] [Reference Citation Analysis]
35 Dar'in D, Kantin G, Kalinin S, Sharonova T, Bunev A, Ostapenko GI, Nocentini A, Sharoyko V, Supuran CT, Krasavin M. Investigation of 3-sulfamoyl coumarins against cancer-related IX and XII isoforms of human carbonic anhydrase as well as cancer cells leads to the discovery of 2-oxo-2H-benzo[h]chromene-3-sulfonamide - A new caspase-activating proapoptotic agent. Eur J Med Chem 2021;222:113589. [PMID: 34147910 DOI: 10.1016/j.ejmech.2021.113589] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
36 Kuzu B, Tan M, Gülçin İ, Menges N. A novel class for carbonic anhydrases inhibitors and evaluation of their non-zinc binding. Arch Pharm (Weinheim) 2021;:e2100188. [PMID: 34096646 DOI: 10.1002/ardp.202100188] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
37 Antal I, Koneracka M, Kubovcikova M, Zavisova V, Jurikova A, Khmara I, Omastova M, Micusik M, Barathova M, Jelenska L, Kajanova I, Zatovicova M, Pastorekova S. Targeting of carbonic anhydrase IX-positive cancer cells by glycine-coated superparamagnetic nanoparticles. Colloids Surf B Biointerfaces 2021;205:111893. [PMID: 34116397 DOI: 10.1016/j.colsurfb.2021.111893] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
38 Dettori I, Fusco I, Bulli I, Gaviano L, Coppi E, Cherchi F, Venturini M, Di Cesare Mannelli L, Ghelardini C, Nocentini A, Supuran CT, Pugliese AM, Pedata F. Protective effects of carbonic anhydrase inhibition in brain ischaemia in vitro and in vivo models. J Enzyme Inhib Med Chem 2021;36:964-76. [PMID: 34056989 DOI: 10.1080/14756366.2021.1907575] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
39 Zhang ZP, Zhong Y, Han ZB, Zhou L, Su HS, Wang J, Liu Y, Cheng MS. Synthesis, Molecular Docking Analysis and Biological Evaluations of Saccharide-Modified Thiadiazole Sulfonamide Derivatives. Int J Mol Sci 2021;22:5482. [PMID: 34067452 DOI: 10.3390/ijms22115482] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
40 Supuran CT. Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 2021;135:1233-49. [PMID: 34013961 DOI: 10.1042/CS20210040] [Cited by in Crossref: 8] [Cited by in F6Publishing: 44] [Article Influence: 8.0] [Reference Citation Analysis]
41 Mincione F, Nocentini A, Supuran CT. Advances in the discovery of novel agents for the treatment of glaucoma. Expert Opin Drug Discov 2021;:1-17. [PMID: 33914670 DOI: 10.1080/17460441.2021.1922384] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
42 Nocentini A, Capasso C, Supuran CT. Small-molecule CD73 inhibitors for the immunotherapy of cancer: a patent and literature review (2017-present). Expert Opin Ther Pat 2021;:1-10. [PMID: 33909515 DOI: 10.1080/13543776.2021.1923694] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
43 Peerzada MN, Hamel E, Bai R, Supuran CT, Azam A. Deciphering the key heterocyclic scaffolds in targeting microtubules, kinases and carbonic anhydrases for cancer drug development. Pharmacol Ther 2021;225:107860. [PMID: 33895188 DOI: 10.1016/j.pharmthera.2021.107860] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
44 Thacker PS, Tiwari PL, Angeli A, Srikanth D, Swain B, Arifuddin M, Supuran CT. Synthesis and Biological Evaluation of Coumarin-Linked 4-Anilinomethyl-1,2,3-Triazoles as Potent Inhibitors of Carbonic Anhydrases IX and XIII Involved in Tumorigenesis. Metabolites 2021;11:225. [PMID: 33917033 DOI: 10.3390/metabo11040225] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
45 Wang H, Tan H, Zhan W, Song L, Zhang D, Chen X, Lin Z, Wang W, Yang Y, Wang L, Bei W, Guo J. Molecular mechanism of Fufang Zhenzhu Tiaozhi capsule in the treatment of type 2 diabetes mellitus with nonalcoholic fatty liver disease based on network pharmacology and validation in minipigs. J Ethnopharmacol 2021;274:114056. [PMID: 33771638 DOI: 10.1016/j.jep.2021.114056] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
46 Sharonova T, Paramonova P, Kalinin S, Bunev A, Gasanov RЕ, Nocentini A, Sharoyko V, Tennikova TB, Dar'in D, Supuran CT, Krasavin M. Insertion of metal carbenes into the anilinic N-H bond of unprotected aminobenzenesulfonamides delivers low nanomolar inhibitors of human carbonic anhydrase IX and XII isoforms. Eur J Med Chem 2021;218:113352. [PMID: 33774343 DOI: 10.1016/j.ejmech.2021.113352] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
47 Elbadawi MM, Eldehna WM, Nocentini A, Abo-Ashour MF, Elkaeed EB, Abdelgawad MA, Alharbi KS, Abdel-Aziz HA, Supuran CT, Gratteri P, Al-Sanea MM. Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. Eur J Med Chem 2021;218:113360. [PMID: 33773285 DOI: 10.1016/j.ejmech.2021.113360] [Cited by in Crossref: 1] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
48 Galati S, Yonchev D, Rodríguez-Pérez R, Vogt M, Tuccinardi T, Bajorath J. Predicting Isoform-Selective Carbonic Anhydrase Inhibitors via Machine Learning and Rationalizing Structural Features Important for Selectivity. ACS Omega 2021;6:4080-9. [PMID: 33585783 DOI: 10.1021/acsomega.0c06153] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
49 Mboge MY, Combs J, Singh S, Andring J, Wolff A, Tu C, Zhang Z, McKenna R, Frost SC. Inhibition of Carbonic Anhydrase Using SLC-149: Support for a Noncatalytic Function of CAIX in Breast Cancer. J Med Chem 2021;64:1713-24. [PMID: 33523653 DOI: 10.1021/acs.jmedchem.0c02077] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
50 Mondal UK, Doroba K, Shabana AM, Adelberg R, Alam MR, Supuran CT, Ilies MA. PEG Linker Length Strongly Affects Tumor Cell Killing by PEGylated Carbonic Anhydrase Inhibitors in Hypoxic Carcinomas Expressing Carbonic Anhydrase IX. Int J Mol Sci 2021;22:1120. [PMID: 33498779 DOI: 10.3390/ijms22031120] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
51 Petreni A, De Luca V, Scaloni A, Nocentini A, Capasso C, Supuran CT. Anion inhibition studies of the Zn(II)-bound ι-carbonic anhydrase from the Gram-negative bacterium Burkholderia territorii. J Enzyme Inhib Med Chem 2021;36:372-6. [PMID: 33390061 DOI: 10.1080/14756366.2020.1867122] [Cited by in Crossref: 3] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
52 Urbański LJ, Angeli A, Hytönen VP, Di Fiore A, De Simone G, Parkkila S, Supuran CT. Inhibition of the β-carbonic anhydrase from the protozoan pathogen Trichomonas vaginalis with sulphonamides. J Enzyme Inhib Med Chem 2021;36:329-34. [PMID: 33356653 DOI: 10.1080/14756366.2020.1863958] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
53 Supuran CT. Experimental Carbonic Anhydrase Inhibitors for the Treatment of Hypoxic Tumors. J Exp Pharmacol 2020;12:603-17. [PMID: 33364855 DOI: 10.2147/JEP.S265620] [Cited by in Crossref: 19] [Cited by in F6Publishing: 45] [Article Influence: 9.5] [Reference Citation Analysis]
54 Petrenko M, Güttler A, Funtan A, Keßler J, Emmerich D, Paschke R, Vordermark D, Bache M. Combined 3-O-acetylbetulin treatment and carbonic anhydrase IX inhibition results in additive effects on human breast cancer cells. Chem Biol Interact 2021;333:109326. [PMID: 33245928 DOI: 10.1016/j.cbi.2020.109326] [Cited by in Crossref: 3] [Cited by in F6Publishing: 11] [Article Influence: 1.5] [Reference Citation Analysis]